Add to watchlist
€232.4
Last updated:06/09/2021
0P8: F
Penumbra, Inc

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombec… Show more

P/E ratio
767.00x
vs. 588.24x forward

Price is 767.00x times more than EPS €0.303 which eaquals €232.4

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
4.657M
6.601M
+41.74%
48.458M
+634.10%
-15.702M
-132.40%
Cashflow
Sum up money going in and out company
12.691M
28.808M
+127.00%
26.652M
-7.48%
-33.242M
-224.73%
Total liabilities
All combined debts and obligations
76.259M
92.591M
+21.42%
180.288M
+94.71%
185.195M
+2.72%
Company profile
CEO
Mr. Adam Elsesser
Market capitalization
Mid (8.56B)